RSVAX vs. MVEIX
Compare and contrast key facts about Victory RS Value Fund (RSVAX) and Monteagle Select Value Fund (MVEIX).
RSVAX is managed by Victory. It was launched on Jun 30, 1993. MVEIX is managed by Monteagle Funds. It was launched on Mar 30, 1998.
Performance
RSVAX vs. MVEIX - Performance Comparison
Loading graphics...
RSVAX vs. MVEIX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
RSVAX Victory RS Value Fund | 1.67% | 4.58% | 12.58% | 7.63% | -2.98% | 27.30% | -2.60% | 31.36% | -10.84% | 17.37% |
MVEIX Monteagle Select Value Fund | 0.87% | 14.79% | 7.97% | 6.60% | -11.14% | 40.11% | 4.89% | 28.29% | -16.96% | 11.14% |
Returns By Period
In the year-to-date period, RSVAX achieves a 1.67% return, which is significantly higher than MVEIX's 0.87% return. Both investments have delivered pretty close results over the past 10 years, with RSVAX having a 8.92% annualized return and MVEIX not far ahead at 9.11%.
RSVAX
- 1D
- 1.80%
- 1M
- -6.09%
- YTD
- 1.67%
- 6M
- 3.14%
- 1Y
- 7.80%
- 3Y*
- 8.50%
- 5Y*
- 7.01%
- 10Y*
- 8.92%
MVEIX
- 1D
- 1.76%
- 1M
- -5.64%
- YTD
- 0.87%
- 6M
- 2.89%
- 1Y
- 16.19%
- 3Y*
- 10.57%
- 5Y*
- 6.13%
- 10Y*
- 9.11%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
RSVAX vs. MVEIX - Expense Ratio Comparison
RSVAX has a 1.30% expense ratio, which is lower than MVEIX's 1.45% expense ratio.
Return for Risk
RSVAX vs. MVEIX — Risk / Return Rank
RSVAX
MVEIX
RSVAX vs. MVEIX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Victory RS Value Fund (RSVAX) and Monteagle Select Value Fund (MVEIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| RSVAX | MVEIX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.50 | 0.93 | -0.43 |
Sortino ratioReturn per unit of downside risk | 0.81 | 1.44 | -0.63 |
Omega ratioGain probability vs. loss probability | 1.11 | 1.19 | -0.08 |
Calmar ratioReturn relative to maximum drawdown | 0.72 | 1.42 | -0.70 |
Martin ratioReturn relative to average drawdown | 2.97 | 5.60 | -2.63 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| RSVAX | MVEIX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.50 | 0.93 | -0.43 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.39 | 0.00 | +0.38 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.47 | 0.01 | +0.46 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.40 | 0.01 | +0.39 |
Correlation
The correlation between RSVAX and MVEIX is 0.79, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
RSVAX vs. MVEIX - Dividend Comparison
RSVAX's dividend yield for the trailing twelve months is around 8.69%, more than MVEIX's 4.57% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
RSVAX Victory RS Value Fund | 8.69% | 8.83% | 9.89% | 6.48% | 6.33% | 14.14% | 1.93% | 7.38% | 15.47% | 25.04% | 12.47% | 9.35% |
MVEIX Monteagle Select Value Fund | 4.57% | 4.83% | 7.76% | 0.53% | 4.32% | 14.24% | 36.67% | 3.44% | 12.07% | 5.70% | 2.71% | 40.45% |
Drawdowns
RSVAX vs. MVEIX - Drawdown Comparison
The maximum RSVAX drawdown since its inception was -59.23%, smaller than the maximum MVEIX drawdown of -97.43%. Use the drawdown chart below to compare losses from any high point for RSVAX and MVEIX.
Loading graphics...
Drawdown Indicators
| RSVAX | MVEIX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -59.23% | -97.43% | +38.20% |
Max Drawdown (1Y)Largest decline over 1 year | -12.06% | -11.84% | -0.22% |
Max Drawdown (5Y)Largest decline over 5 years | -23.58% | -97.43% | +73.85% |
Max Drawdown (10Y)Largest decline over 10 years | -43.49% | -97.43% | +53.94% |
Current DrawdownCurrent decline from peak | -6.16% | -96.64% | +90.48% |
Average DrawdownAverage peak-to-trough decline | -13.88% | -14.80% | +0.92% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.92% | 3.01% | -0.09% |
Volatility
RSVAX vs. MVEIX - Volatility Comparison
Victory RS Value Fund (RSVAX) has a higher volatility of 4.16% compared to Monteagle Select Value Fund (MVEIX) at 3.77%. This indicates that RSVAX's price experiences larger fluctuations and is considered to be riskier than MVEIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| RSVAX | MVEIX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.16% | 3.77% | +0.39% |
Volatility (6M)Calculated over the trailing 6-month period | 9.05% | 9.30% | -0.25% |
Volatility (1Y)Calculated over the trailing 1-year period | 16.29% | 17.49% | -1.20% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.18% | 1,967.04% | -1,948.86% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 19.20% | 1,391.05% | -1,371.85% |